CDK12 promotes papillary thyroid cancer progression through regulating the c-myc/β-catenin pathway

Background: CDK12 is a potential therapeutic target in papillary thyroid cancer that regulates the c-myc/β-catenin pathway. Objective: We aimed to explore the specific mechanism of CDK12 in papillary thyroid cancer and provide a new target of cancer therapy. Methods: RT-qPCR was used to determine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Ning, Xia, Fada, Wang, Wenlong, Lei, Yao, Bo, Jiang, Li, Xinying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255385/
https://www.ncbi.nlm.nih.gov/pubmed/32489449
http://dx.doi.org/10.7150/jca.42849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255385/
https://www.ncbi.nlm.nih.gov/pubmed/32489449
http://dx.doi.org/10.7150/jca.42849

Ejemplares similares